Teresa Gravina

Dr. Teresa Gravina

Dept. of Translational Medicine (DIMET), Università del Piemonte Orientale, Novara, Piedmont, Italy
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
Teresa GravinaTeresa Gravina
Teresa Gravina
Chiara Maria Teresa BoggioChiara Maria Teresa Boggio
Chiara Maria Teresa Boggio
EGElisa Gorla
Elisa Gorla
LRLuisa Racca
Luisa Racca
SPSilvia Polidoro
Silvia Polidoro
Gianluca BaldanziGianluca Baldanzi
Gianluca Baldanzi
Diacylglycerol kinases (DGKs) play dual roles in cell transformation and immunosurveillance. According to cancer expression databases, acute myeloid leukemia (AML) exhibits significant overexpression of multiple DGK isoforms, including DGKA, DGKD and DGKG, without a precise correlation with specific AML subtypes. In the TGCA database, high DGKA expression negatively correlates with survival, while high DGKG expression is associated with a more favorable prognosis. DGKA and DGKG also feature different patterns of co-expressed genes. Conversely, the BeatAML and TARGET databases show that high DGKH expression is correlated with shorter survival. To assess the suitability of DGKs as therapeutic targets, we treated HL-60 and HEL cells with DGK inhibitors and compared cell growth and survival with those of untransformed lymphocytes. We observed a specific sensitivity to R59022 and R59949, two poorly selective inhibitors, which promoted cytotoxicity and cell accumulation in the S phase in both cell lines. Conversely, the DGKA-specific inhibitors CU-3 and AMB639752 showed poor efficacy. These findings underscore the pivotal and isoform-specific involvement of DGKs in AML, offering a promising pathway for the identification of potential therapeutic targets. Notably, the DGKA and DGKH isoforms emerge as relevant players in AML pathogenesis, albeit DGKA inhibition alone seems insufficient to impair AML cell viability.

30 October 2024 in Biology Direct
Verified
Journal Article
Open access
PDF file
FFFrancesco Favero
Francesco Favero
ARAngela Re
Angela Re
MDMohammed Salim Dason
Mohammed Salim Dason
Teresa GravinaTeresa Gravina
Teresa Gravina
MGMara Gagliardi
Mara Gagliardi
Davide CoràDavide Corà
Davide Corà
Alzheimer’s disease (AD) is a complex neurodegenerative disorder significantly impairing cognitive faculties, memory, and physical abilities. To characterize the modulation of the gut microbiota in an in vivo AD model, we performed shotgun metagenomics sequencing on 3xTgAD mice at key time points (i.e., 2, 6, and 12 months) of AD progression. Fecal samples from both 3xTgAD and wild-type mice were collected, DNA extracted, and sequenced. Quantitative taxon abundance assessment using MetaPhlAn 4 ensured precise microbial community representation. The analysis focused on species-level genome bins (SGBs) including both known and unknown SGBs (kSGBs and uSGBs, respectively) and also comprised higher taxonomic categories such as family-level genome bins (FGBs), class-level genome bins (CGBs), and order-level genome bins (OGBs). Our bioinformatic results pinpointed the presence of extensive gut microbial diversity in AD mice and showed that the largest proportion of AD- and aging-associated microbiome changes in 3xTgAD mice concern SGBs that belong to the Bacteroidota and Firmicutes phyla, along with a large set of uncharacterized SGBs. Our findings emphasize the need for further advanced bioinformatic studies for accurate classification and functional analysis of these elusive microbial species in relation to their potential bridging role in the gut-brain axis and AD pathogenesis.

1 November 2025 in Cells
Verified
Journal Article
Open access
PDF file
EGElisa Gorla
Elisa Gorla
MCMarco Cristiano Cristiano Cartella
Marco Cristiano Cristiano Cartella
EBEdoardo Borghetti
Edoardo Borghetti
Ginevra LovatiGinevra Lovati
Ginevra Lovati
LRLuisa Racca
Luisa Racca
Gianluca BaldanziGianluca Baldanzi
Gianluca Baldanzi
Acute myeloid leukemia (AML) is a heterogeneous disease with an unmet need for novel therapeutic drugs. Previous studies have reported the upregulation of diacylglycerol kinases (DGKs) in AML. This study investigated the effects of ritanserin, a DGKα-specific inhibitor, and DGKζ-IN4 or BAY 2965501, DGKζ-selective inhibitors, on a panel of AML cell lines. Ritanserin induced apoptotic cell death across all tested models, whereas DGKζ inhibitors triggered both apoptosis and necrosis to variable extents, with HL-60 cells being the most responsive to both compounds. Drug sensitivity did not correlate with DGKα or DGKζ expression levels, indicating that additional factors may influence cellular susceptibility. THP-1 proteomic profiling revealed that ritanserin broadly downregulated proteins involved in antigen presentation, cell cycle and metabolism, while BAY 2965501 affected a smaller and distinct but functionally similar protein subset, implying different mechanisms of action. Gene silencing confirmed AML cell line-specific dependence on DGK isoforms: HEL cells were sensitive to DGKα knockdown, HL-60 to DGKζ silencing, whereas K562 and THP-1 were resistant to both. These findings indicate that DGKs targeting can effectively reduce AML cell viability. However, AML heterogeneity and the limited selectivity of current inhibitors underscore the need for predictive biomarkers and combinatorial strategies to translate DGK inhibition into effective therapy.

Verified
Journal Article
Open access
PDF file
Teresa GravinaTeresa Gravina
Teresa Gravina
FFFrancesco Favero
Francesco Favero
SRStefania Rosano
Stefania Rosano
SPSushant Parab
Sushant Parab
AAAlejandra Diaz Alcalde
Alejandra Diaz Alcalde
Davide CoràDavide Corà
Davide Corà
Various human diseases are triggered by molecular alterations influencing the fine-tuned expression and activity of transcription factors, usually due to imbalances in targets including protein-coding genes and non-coding RNAs, such as microRNAs (miRNAs). The transcription factor EB (TFEB) modulates human cellular networks, overseeing lysosomal biogenesis and function, plasma–membrane trafficking, autophagic flux, and cell cycle progression. In endothelial cells (ECs), TFEB is essential for the maintenance of endothelial integrity and function, ensuring vascular health. However, the comprehensive regulatory network orchestrated by TFEB remains poorly understood. Here, we provide novel mechanistic insights into how TFEB regulates the transcriptional landscape in primary human umbilical vein ECs (HUVECs), using an integrated approach combining high-throughput experimental data with dedicated bioinformatics analysis. By analyzing HUVECs ectopically expressing TFEB using ChIP-seq and examining both polyadenylated mRNA and small RNA sequencing data from TFEB-silenced HUVECs, we have developed a bioinformatics pipeline mapping the different gene regulatory interactions driven by TFEB. We show that TFEB directly regulates multiple miRNAs, which in turn post-transcriptionally modulate a broad network of target genes, significantly expanding the repertoire of gene programs influenced by this transcription factor. These insights may have significant implications for vascular biology and the development of novel therapeutics for vascular disease.

23 October 2026 in Science Advances
Verified
Journal Article
Closed access
SPSimone Pelicci
Simone Pelicci
LFLaura Furia
Laura Furia
LCLorenzo Ciacci
Lorenzo Ciacci
Teresa GravinaTeresa Gravina
Teresa Gravina
Pier Giuseppe PelicciPier Giuseppe Pelicci
Pier Giuseppe Pelicci
MFMario Faretta
Mario Faretta
Understanding how molecular mechanisms regulate cell function in tissues requires approaches that link phenotypes to mechanisms across different spatial scales. Here, we present automated multimodal multiplexed microscopy for image cytometry (A.M 3 .I.CO), a correlative imaging platform that combines multiscale resolution, from millimeters to nanometers, with automated workflows for high-throughput phenotypic profiling and targeted single-molecule analysis in situ. Applying A.M 3 .I.CO, we observed that 53BP1 is recruited at transcribed p53 target genes independently of the activating stimulus, providing evidence for the formation of a putative complex between 53BP1, p53, and the basal transcription machinery in single cells, as also supported by in vivo observations in tumor models. Extending our measurements to p63 and p73, we found that 53BP1 localized at p63- and p73-targeted transcription sites, suggesting a broader role in participating in p53 family–dependent transcription. These findings indicate an additional genome-surveillance pathway in transcriptional control regulating diverse cellular functions while establishing A.M 3 .I.CO as a platform for spatially resolved functional analysis.